Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers. / Madsen, P L; Vorstrup, S; Schmidt, J F; Paulson, O B.
In: European Journal of Clinical Pharmacology, Vol. 39, No. 3, 1990, p. 295-7.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers
AU - Madsen, P L
AU - Vorstrup, S
AU - Schmidt, J F
AU - Paulson, O B
PY - 1990
Y1 - 1990
N2 - The effect of acute and long-term treatment with propranolol on cerebral blood flow (CBF) and the cerebral metabolic rate of oxygen (CMRO2) has been studied in 8 young healthy volunteers. CBF was measured by 133Xe-inhalation and single photon emission computer tomography, and CMRO2 was calculated from the arterio-venous oxygen difference and CBF. Studies were done before and 1 h after i.v. injection of 5 mg propranolol and after three weeks on oral propranolol 80 mg/d for 1 week and 160 mg/d for 2 weeks. Cerebrovascular CO2 reactivity in terms of the A-V oxygen difference was tested on all three occasions during hypercapnia and hyperventilation. CBF, CMRO2 and cerebrovascular CO2 reactivity remained stable both after acute and after 3 weeks of treatment with propranolol.
AB - The effect of acute and long-term treatment with propranolol on cerebral blood flow (CBF) and the cerebral metabolic rate of oxygen (CMRO2) has been studied in 8 young healthy volunteers. CBF was measured by 133Xe-inhalation and single photon emission computer tomography, and CMRO2 was calculated from the arterio-venous oxygen difference and CBF. Studies were done before and 1 h after i.v. injection of 5 mg propranolol and after three weeks on oral propranolol 80 mg/d for 1 week and 160 mg/d for 2 weeks. Cerebrovascular CO2 reactivity in terms of the A-V oxygen difference was tested on all three occasions during hypercapnia and hyperventilation. CBF, CMRO2 and cerebrovascular CO2 reactivity remained stable both after acute and after 3 weeks of treatment with propranolol.
KW - Administration, Oral
KW - Adult
KW - Blood Pressure/drug effects
KW - Cerebrovascular Circulation/drug effects
KW - Dose-Response Relationship, Drug
KW - Female
KW - Heart Rate/drug effects
KW - Humans
KW - Injections, Intravenous
KW - Male
KW - Oxygen/metabolism
KW - Propranolol/administration & dosage
KW - Tomography, Emission-Computed, Single-Photon
U2 - 10.1007/BF00315115
DO - 10.1007/BF00315115
M3 - Journal article
C2 - 2257870
VL - 39
SP - 295
EP - 297
JO - European Journal of Clinical Pharmacology
JF - European Journal of Clinical Pharmacology
SN - 0031-6970
IS - 3
ER -
ID: 275129497